Cannabis is an exciting opportunity for many companies in the industry. With every single advancement, there is an expansion, and the result is increased productivity. Twenty years ago, Radient Technologies Inc. (OTCMKTS:RDDTF) discovered the opportunity and a new era of business; cannabis. Through a research scientist who had a vision, the company created superior and competitive technology, which would offer extraction solutions.
There was consistent growth of the company’s vision, and in 2005 it signed its first supply agreement with a US-based biopharmaceutical company. This came with increased responsibilities, hence the need for new, bigger laboratories and plants. By 2018, the skyrocketing demand was outdoing the production capacity its North York and Whitby. This resulted in the construction of a new 20,000 sq. ft. plant in Edmonton, Alberta.
New Milestones and Critical Steps for Diversification of Radient’s Business Model
The Canadian based company has been consistent in its path of success, and today it is a global commercial manufacturer of superior cannabinoid-based ingredients. It has also accomplished another milestone in obtaining a Health Canada license amendment to allow the sale of cannabis extracts, edibles, and topicals. The amendment gives the company a leeway to launch its product portfolio and commercialize its products.
“Receiving this license amendment is a critical step in diversifying and evolving Radient’s business model… The sales license will give Radient the ability to leverage our unique formulations for exciting new consumer products.” This is according to the company’s CEO Denis Taschuk.
The Process of Capturing New Revenue Opportunities and Agreements
Radient believes in taking advantage of the slightest opportunity at hand. It is in the process of expanding its product manufacturing capabilities. In the coming month, the manufacturer will be announcing to its stakeholders and customers the innovative offerings. It has established operations out of Spain and Germany.
Meanwhile, Radient has an agreement with Premium 5, Canada’s provider of the unique and custom concentrate products extracted through hydrocarbon and solventless methods. Since the launch of its first live resin concentrates in the country, P5 has become synonymous with the highest levels of innovative products.
 Receives Health Canada License Amendment for the Sale of Three Categories of Extracted Products){kind=link}